Ironwood Pharmaceuticals, Inc. (IRWD) Financials

IRWD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 471.1 million 817.4 million
2023-09-30 524.1 million 849.7 million
2023-06-30 603.2 million 950.0 million
2023-03-31 1.2 billion 448.4 million

IRWD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 35.6 million 8.7 million
2023-09-30 32.4 million 7.9 million
2023-06-30 35.0 million 8.3 million
2023-03-31 80.2 million 7.1 million

IRWD Net Income

No data available :(

IRWD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 92.2 million - 17.7 million
2023-09-30 110.2 million - 18.2 million
2023-06-30 175.3 million 598.0 million 18.7 million
2023-03-31 740.3 million 396.7 million 19.2 million

IRWD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 156.0 million
2023-09-30 186.9 million
2023-06-30 155.4 million
2023-03-31 186.7 million

IRWD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 211000 35.1 million 38.7 million -
2023-09-30 49000 33.0 million 36.0 million -
2023-06-30 - 1.1 billion 52.5 million -
2023-03-31 13000 12.8 million 31.1 million -

IRWD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 117.6 million 512000
2023-09-30 113.7 million 507000
2023-06-30 107.4 million 270000
2023-03-31 104.1 million 286000

IRWD

Price: $8.12

52 week price:
7.60
15.70

Earnings Per Share: -6.45 USD

P/E Ratio: -2.43

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 405820

Ebitda: 26.2 million

Market Capitalization: 1.2 billion

Links: